News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global regulators and banks pressed tech firms over Anthropic's Mythos, prompting restricted rollouts and heightened cybersecurity scrutiny in the financial sector.
  • U.S. stocks closed mixed as Nasdaq rose while the Dow lagged and volatility fell to a one-month low.
  • Canada's TSX rose to a one-month high led by Materials, Energy and IT, while Brazil's Bovespa hit a record close.
  • Seaport Therapeutics filed for a Nasdaq IPO and Blackstone filed to list its data-center trust, signalling ongoing IPO activity.
  • Rio Tinto's California boron asset drew over a dozen potential bidders and could fetch about $2 billion.
  • A U.S. delegation led by VP JD Vance heads to Islamabad for Iran ceasefire talks amid skepticism and tough Iranian preconditions.

Latest Articles

Solo Brands director Tarbox purchases roughly $9,000 in Class A shares

Solo Brands director Tarbox purchases roughly $9,000 in Class A shares

Andrea K. Tarbox, a director at Solo Brands, Inc. (NYSE: SBDS), acquired 2,211 shares of Class A common stock on March 30, 2026, for about $9,000, according to a Form 4 filing. The transaction occurred at a weighted average price of $4.0707 per share, with individual trade prices between $3.725 and $4.29. The stock is trading below the purchase pri…

Tate & Lyle's CEO Nick Hampton Expected to Exit After Eight Years

Tate & Lyle's CEO Nick Hampton Expected to Exit After Eight Years

Nick Hampton, who became Tate & Lyle's CEO in April 2018 after joining the company as CFO in 2014, is reportedly preparing to step down after eight years leading the food ingredients supplier. The company has engaged headhunters to identify a replacement and a departure could occur as soon as this year. Tate & Lyle's shares have fallen sharply unde…

Trump Tells Allies to 'Take' the Strait of Hormuz or Purchase U.S. Jet Fuel

Trump Tells Allies to 'Take' the Strait of Hormuz or Purchase U.S. Jet Fuel

President Donald Trump posted on Truth Social urging countries unable to secure jet fuel because of a closure of the Strait of Hormuz to either buy fuel from the United States or mount military action themselves to reopen the waterway. He said the U.S. would not help allies in such efforts and signaled a willingness to end the U.S. military campaig…

Barclays Lifts Domino’s Pizza UK to Equal Weight, Cites Better Franchisee Margins and Chick ’N’ Dip Strategy

Barclays Lifts Domino’s Pizza UK to Equal Weight, Cites Better Franchisee Margins and Chick ’N’ Dip Strategy

Barclays upgraded Domino’s Pizza UK & Ireland from underweight to equal weight and set a 190p price target versus a March 27 closing price of 171p. The broker pointed to stronger-than-expected franchisee profitability in FY25 and management’s decision to halt pursuit of a standalone chicken brand as key drivers for the change. Barclays modelled a r…

Plus Therapeutics Announces Reverse Stock Split

Plus Therapeutics Announces Reverse Stock Split

Plus Therapeutics declares a 1-for-25 reverse stock split effective April 2, 2026, to increase its share price and comply with Nasdaq's minimum $1.00 bid price rule. The company's common stock will continue trading on the Nasdaq Capital Market under the symbol PSTV, with proportional adjustments made to outstanding shares, equity awards, and warran…

Cloudastructure Inc. Reaffirms Prior Guidance of  Approximately 270% Year-Over-Year Revenue Growth and More Than $5.0 Million in Recognized Revenue in 2025;  Rescheduling Fiscal Year 2025 Conference Call

Cloudastructure Inc. Reaffirms Prior Guidance of Approximately 270% Year-Over-Year Revenue Growth and More Than $5.0 Million in Recognized Revenue in 2025; Rescheduling Fiscal Year 2025 Conference Call

Cloudastructure, Inc., a leader in AI surveillance and remote guarding, reaffirmed its prior guidance predicting approximately 270% year-over-year revenue growth and over $5 million in recognized revenue for fiscal year 2025. The company also announced it will reschedule its conference call to discuss these financial results due to a scheduling con…

Orphaned in Beirut: Syrian Girl's Childhood Shattered by Israeli Strike

Orphaned in Beirut: Syrian Girl's Childhood Shattered by Israeli Strike

A 12-year-old Syrian girl, Nariman al-Issa, lost her parents and siblings in an Israeli strike that demolished their home in Beirut's southern suburbs. Now living on the street with relatives, she survives on charity while her family has lost its incomes and has no alternative home. The incident is one among hundreds of civilian casualties and mass…

Deutsche Bank Raises Rating on Diageo to Buy While Trimming Valuation

Deutsche Bank Raises Rating on Diageo to Buy While Trimming Valuation

Deutsche Bank moved Diageo to a buy rating from hold while cutting its price target to 1,650p from 1,790p, reflecting downgraded earnings estimates and expected margin compression. The bank forecasts a recovery in profitability in FY27 but models EPS well below consensus for FY27 and FY28, and assumes notable EBIT margin reductions in North America…

Odysight.ai® Announces Dual Listing on the Tel Aviv Stock Exchange

Odysight.ai® Announces Dual Listing on the Tel Aviv Stock Exchange

Odysight.ai Inc., a US-incorporated AI-based visual sensing solutions provider for predictive maintenance and condition monitoring, has announced approval for dual listing on the Tel Aviv Stock Exchange (TASE). The company's shares will begin trading on TASE under the ticker ODYS on April 9, 2026, in addition to its existing Nasdaq listing. This mo…

Sandisk: Market Overreacts to TurboQuant—Buy the Tactical Pullback

Sandisk: Market Overreacts to TurboQuant—Buy the Tactical Pullback

Shares of Sandisk (SNDK) have been punished after news about Google's TurboQuant compression algorithm. The sell-off creates a tactical long opportunity. Sandisk's exposure to robust AI infrastructure demand, positive free cash flow, and limited near-term supply elasticity argue the stock's downside is smaller than current market moves imply. Trade…

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

Tonix Pharmaceuticals announced promising Phase 1 results for TNX-4800, a long-acting monoclonal antibody aimed at preventing Lyme disease with a single dose offering about four months of protection. The company plans to initiate a randomized, double-blind, placebo-controlled Phase 2 field study in the first half of 2027 pending FDA clearance, targ…

GXO Strengthens Its Presence in Switzerland with Opening of Sant’Antonino Site, a Future-Ready Logistics Hub

GXO Strengthens Its Presence in Switzerland with Opening of Sant’Antonino Site, a Future-Ready Logistics Hub

GXO Logistics has opened a new technologically advanced and sustainable logistics hub in Sant’Antonino, Switzerland. The facility enhances the company’s footprint in Continental Europe, featuring cutting-edge automation and a strong ESG focus. The hub’s strategic location bolsters supply chain efficiency between Northern and Southern Europe, suppor…

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

Biomea Fusion has initiated two Phase II clinical trials (COVALENT-211 and COVALENT-212) testing their drug icovamenib in distinct type 2 diabetes populations failing existing standard-of-care treatments. Early studies showed promising and durable glycemic control benefits, prompting advancement to larger, targeted studies with topline data expecte…

Barclays Predicts Strong Rebound in European Energy Profits

Barclays Predicts Strong Rebound in European Energy Profits

Barclays forecasts a marked recovery in earnings for European energy companies, citing higher crude and natural gas prices, improved refining margins and potential trading gains amid increased market volatility. Updated forecasts place FY26 estimates well ahead of consensus, while returns on capital are expected to climb to levels last seen when Br…

Wells Fargo Lowers S&P Year-End Target, Sees Conflict Risk Outweighing Oil

Wells Fargo Lowers S&P Year-End Target, Sees Conflict Risk Outweighing Oil

Wells Fargo analyst Ohsung Kwon reduced the bank's year-end S&P 500 target from 7,800 to 7,300, citing the Iran war as a new, material risk that was not part of the firm's baseline for 2026. The bank's PRSM model still points to a positive 12-month return, supported by earnings upgrades for 2026 and 2027, but Kwon warns that market pricing already …